The transactions were announced a year ago right after a Supreme Court decision that left subsidies for the federal health exchange intact.
US antitrust officials are ready to file suits to block 2 giant managed care mergers—Aetna’s takeover of Humana and Anthem’s deal to acquire Cigna, according to a report by Bloomberg.
The 2 mammoth mergers would consolidate the nation’s largest insurers down from 5 companies to just 3. Critics of the deals say the mergers would leave the US healthcare system uncompetitive in too many markets, which would drive up healthcare costs for consumers.
Final word on a possible move to block the mergers could come this week or next, according to the Bloomberg report. The US Justice Department did not comment. Antitrust regulators can move to block merger completely or require asset sales in certain markets to keep them competitive.
The deals took shape last summer after the Supreme Court of the United States declined to unravel the subsidies created by the Affordable Care Act, which make policies affordable for low- and middle-income consumers shopping on the federal exchange, HealthCare.gov.
Aetna announced July 3, 2015, that it planned to acquire Humana for $37 billion to create a combined company controlling about 25% of the market. Anthem followed July 24, 2015, with a proposed $54 billion takeover of Cigna, which would create the largest managed care company in the country, eclipsing UnitedHealth Group. The combined Anthem-Cigna company would control 29% of the market, according to Bloomberg data.
Aetna’s interest in Humana would create a company that would get more than half its revenue from Medicare plans, with Humana’s existing Louisville headquarters serving as the hub for Medicare business.
The transactions need blessing not only from the Justice Department, but also from regulators in states where approval is required. So far, Aetna has won approvals in 18 of the 20 states while Anthem has sign off in 10 of 24 states.
The mergers have been opposed by the American Medical Association, which asked antitrust officials to block the deals. The American Hospital Association told its members that a number of US senators have asked the Justice Department to halt the mergers, including US Senator Richard Blumenthal of Connecticut, where Aetna is based.
If the deals fail, analysts have predicted that there will be more buying up of smaller health plans by the remaining giants.
CMS released a final rule to help patients obtain Children’s Health Insurance Program (CHIP) coverage and issued a proposed rule to update Medicare payment policies and rates for inpatient rehabilitation facilities; debate over if gift card incentives are acceptable in health care marketing.
Read More
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
A global AIDS program that was in limbo for months got temporary relief after congressional negotiators agreed to a 1-year renewal in the next government funding package; the outcome of the November presidential election could determine the state of fetal tissue research in the US; federal officials and industry executives failed to make improvements that stop hacking attacks.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Fragmented Payer System, Vulnerable Supply Chain Among Threats to Accessing Essential Medicines
March 13th 2024During a session of the 2024 V-BID Summit, panelists Stacie Dusetzina, PhD, and Inma Hernandez, PharmD, PhD, discussed how access to essential medications is curtailed not just by the longstanding complexities of insurance design but also by emerging threats such as supply chain weaknesses and cyberattacks.
Read More
Most private health insurers have yet to publish criteria for when they will cover postpartum depression drug, zuranolone; state lawmakers are increasingly opposing health care mergers that they believe do not serve the public interest; Medicaid extensions made in 2021 led to a 40% decline in postpartum lack of insurance.
Read More